TaiMed Biologics (4147 TWO), an innovation-driven biotech company, has Phase 2a clinical study evaluating TMB-365/TMB-380 ...
The Hanwha Group, a major South Korean arms manufacturer, intends to build an arms factory in Romania's southern Dâmbovița ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback